A research lab in Australia has announced clinical trials for a possible vaccine against COVID-19.

Scientists all around the world are grappling to find a vaccine for the novel virus which appeared in China last December and has since killed over 139,400 people globally and infected an upward of 2.08 million others.

Nucleus Network said in a statement on Wednesday it will jointly hold trials with Novavax, a bio-tech company based in the U.S.

“Nucleus has a rich history of Phase 1 vaccine trials, and a long-standing track-record with Novavax; we are well positioned to implement rapid testing with

Read more: Australian lab to hold anti-COVID-19 vaccine trials